Your session is about to expire
← Back to Search
Screening Methods for Swallowing Disorders
N/A
Recruiting
Led By Oliver Acosta, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying ways to check for swallowing problems in stroke patients. It focuses on people who have had a stroke because they often have trouble swallowing. The tests help doctors find out if these patients are at risk of health issues from swallowing difficulties.
Who is the study for?
This trial is for adults aged 18-80 who've had an ischemic stroke within the last month and are at Lynn Rehabilitation Center. They must understand English or Spanish, be able to consent (or have a proxy do so), and not have a history of swallowing issues or certain brain injuries.
What is being tested?
The study compares two tests for dysphagia after an ischemic stroke: one is a non-standardized clinical evaluation, and the other uses the Mann Assessment of Swallowing Ability. It aims to identify which better detects swallowing difficulties and aspiration risk.
What are the potential side effects?
Since this trial involves screening tools rather than medications, there are no direct side effects from interventions. However, discomfort during swallow evaluations may occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 20 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Deglutition Disorders
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Non-standardized clinical swallow evaluation GroupExperimental Treatment1 Intervention
Participants in this group will receive standard of care treatment (dysphagia screening once upon admission to inpatient rehabilitation using a non-standardized clinical swallow evaluation for approximately 15 minutes).
Group II: Mann Assessment of Swallowing Ability (MASA) GroupExperimental Treatment1 Intervention
Participants in this group will receive the MASA dysphagia screening once upon admission to inpatient rehabilitation for approximately 20 minutes.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for swallowing difficulty include dietary modifications, swallowing therapy, and medical or surgical interventions. Dietary modifications involve altering food texture and consistency to make swallowing safer and easier.
Swallowing therapy, often conducted by speech-language pathologists, focuses on exercises and techniques to strengthen the muscles involved in swallowing and improve coordination. Medical interventions may include medications to manage underlying conditions, while surgical options can address structural abnormalities.
These treatments are crucial for dysphagia patients as they help prevent aspiration, improve nutritional intake, and enhance overall quality of life. Accurate screening tests for dysphagia and aspiration risk are essential to tailor these treatments effectively and ensure patient safety.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
948 Previous Clinical Trials
427,720 Total Patients Enrolled
Oliver Acosta, MDPrincipal InvestigatorUniversity of Miami
Gemayaret Alvarez, MDPrincipal InvestigatorUniversity of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am over 80 years old.I was admitted to Lynn Rehabilitation Center for a recent stroke.I can understand instructions in English or Spanish.I have not had a recent serious brain injury or bleeding.I can give my consent, or someone can do it for me if I'm unable.
Research Study Groups:
This trial has the following groups:- Group 1: Mann Assessment of Swallowing Ability (MASA) Group
- Group 2: Non-standardized clinical swallow evaluation Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger